Skip to content

What You Need to Know About CBD Product Labeling Regulations

CBD Hemp oil, Hand holding droplet of Cannabis oil against Marijuana buds. Alternative Medicine

From CBD product labels that claim to diagnose, cure, mitigate, treat, or prevent disease to truth-in-advertising requirements — LegitScript explores the regulatory environment of CBD as it exists today. Then download our CBD Compliance Resource Guide or create an account to apply for your CBD Certification.

What Is a Claim? And How It Relates to CBD Regulations Surrounding Product Labeling

A claim refers to any statement pertaining to the effects or results of using a product. As per the US Food and Drug Administration (FDA), a drug is defined as an article intended for use in diagnosing, curing, mitigating, treating, or preventing diseases in humans or animals, or is meant to affect body structure or function. Therefore, if a product is intended for any of these uses, it is considered a drug and must be FDA-approved. With limited exceptions, CBD products are not FDA-approved; therefore any disease or structure/function claims pertaining to these products is misleading.

Alongside the FDA, the Federal Trade Commission (FTC) plays a crucial role in regulating these claims and enforces truth-in-advertising requirements. It is illegal to claim that a product can prevent, treat, or cure human diseases without scientific evidence. Examples of misleading claims include stating that a product can help with diseases such as cancer or depression, affect body function or structure, or aid in weight loss.

Violation of these regulations can result in warnings or disciplinary actions from the FDA and FTC. Thus, compliance with federal and state regulations is vital to avoid deceptive practices that might defraud customers, regulators, or the public. State-level regulations may also apply, as seen in states like Utah and West Virginia, which have specific rules about product labels and advertising. Compliance is therefore critical for maintaining customer trust and mitigating legal and regulatory risks.

CBD Product Labeling Regulations and Compliance

In addition to claims about health benefits, product labeling is also a crucial aspect of compliance in the CBD industry. The FDA has strict rules on how CBD products should be labeled, and failure to comply can result in penalties or warning letters. This includes accurately listing ingredients, proper dosage information, and clear disclaimers about the potential risks and side effects of using CBD.

Download LegitScript’s CBD Compliance Resource Guide for a Comprehensive Breakdown

Are you a CBD manufacturer or retailer curious about how to remain compliant with product labeling regulations? Download LegitScript’s CBD Compliance Resource Guide for a comprehensive and detailed breakdown of how to maintain compliance with regulatory bodies across jurisdictions.

LegitScript’s CBD Certification Ensures Your Compliance With CBD Labeling Requirements

It's essential for businesses operating within the CBD industry today to stay informed about the laws impacting them to ensure they remain compliant. LegitScript’s CBD Certification supports businesses in maintaining continued compliance through active monitoring — and unlocks advertising on Google and select Meta platforms. Continued compliance with all regulatory requirements is essential for CBD businesses to build trust with consumers, establish credibility, and maintain long-term success in the market.

Create an account to start the application process today.

Smelting words into subject matter expertise since 2020, Thea Le Fevre specializes in B2B SaaS Content Marketing. She believes in embracing innovation and produces AI-assisted content along with organically crafted content. Take a deep dive into her work for up-to-date industry news surrounding issues in trust & safety, payments risk & compliance, healthcare, and more.

Recent Blog Articles

Problematic Product Spotlight: Tianeptine

LegitScript has observed a recent rise in both the popularity and regulatory scrutiny of tianeptine, an unregulated substance commonly sold in gas stations and online - and often marketed with unproven claims to be a cognitive enhancer as well as an alternative to opioids. As such, manufacturers hav...
EU’s Strategy to Combat Counterfeiting

What You Need to Know About the EU’s Strategy to Combat Counterfeiting

In an effort to strengthen intellectual property (IP) rights, the European Commission recently adopted a recommendation on initiatives intended to curb counterfeiting activities both online and offline. This post discusses the strategy, adopted recommendations, and new approaches to stopping the sal...

This Piece of Legislation Redefined Hemp for an Entire Nation

The 2018 Farm Bill redefined the legal definition for hemp, and with that change unearthed a nationwide market for hemp-derived CBD products. Learn more about the Farm Bill, explore the current regulatory landscape for hemp and CBD products, and then download LegitScript's CBD Compliance Resource Gu...
Invest in trust and safety.

A Recent Report Recommends Investing in Trust and Safety

In the recent Trust and Safety Market Research Report published by Duco, researchers found that investment in trust and safety is increasingly important and that solutions like LegitScript's Ad Monitoring and Marketplace Monitoring can accelerate these efforts while providing a solid return on inves...